Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF

Figure 3

Comparisons of CAT, CST, CV, and VEGF of two groups before and after treatment. The treatment group’s CAT, CST, and CV levels (a, b, and c) were all significantly lower after treatment, and there were no significant differences of control group’s CAT, CST, and CV levels before and after treatment. The serum VEGF level (d) in the treatment group was significantly lower after treatment, and there was no significant difference of control group’s VEGF before and after treatment. T: treatment; C: control.

(a)

(b)

(c)

(d)